Odeon Capital analyst Dick Bove downgrades KeyCorp (NYSE:KEY) from Buy to Hold.
Pear Therapeutics Explores Strategic Options; May Seek Reorganization If Unable To Complete Transaction
Pear Therapeutics Inc (NASDAQ:PEAR) is engaged in a process to explore strategic alternatives. The company has engaged MTS Health Partners,…